Hyaluronic Acid Filler IMD1 Basic for Correction of Nasolabial Folds
Prospective, Multicentre, Not Controlled Clinical Study to Investigate Efficacy and Tolerability of the Hyaluronic Acid Filler IMD1 Basic After Single Bilateral Injection for Correction of Nasolabial Folds (NLF)
1 other identifier
interventional
114
1 country
1
Brief Summary
Volunteers receive one injection IMD1 basic of correction of nasolabial folds and are followed-up for up to 36 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Dec 2005
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2006
CompletedFirst Submitted
Initial submission to the registry
January 30, 2007
CompletedFirst Posted
Study publicly available on registry
January 31, 2007
CompletedFebruary 7, 2008
February 1, 2008
January 30, 2007
February 5, 2008
Conditions
Outcome Measures
Primary Outcomes (1)
Severity rating scale assessed by independent rater
Interventions
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Merz Pharmaceuticals
Frankfurt, 60318, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Johannes Reinmüller, MD
Klinik am Sonnenberg, Wiesbaden, Germany
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
January 30, 2007
First Posted
January 31, 2007
Study Start
December 1, 2005
Study Completion
December 1, 2006
Last Updated
February 7, 2008
Record last verified: 2008-02